HOME
SEARCH
RSS FEED
SUBSCRIBE
Clones Encoding Mammalian ADP-Ribosylarginine Hydrolases
Case ID:
TAB-399
Web Published:
12/6/2022
Description:
ADP-ribosylation of arginine residues in proteins may be involved in cell adhesion and is crucial for the action of cholera toxin and E. coli heat-labile enterotoxin, agents involved in the pathogenesis of cholera and traveller's diarrhoea, respectively. ADP-ribosylation is reversed by ADP-ribosylarginine hydrolases, which cleave the ADP-ribose-arginine bond. ADP-ribosylarginine hydrolases from a variety of mammalian species and tissues were isolated, and the coding regions for the hydrolases were cloned and expressed. The availability of this new hydrolase cDNA and expression system provides a novel molecular approach for studying the role of ADP-ribosylation in cell function. The gene products may be useful in treating or preventing a variety of bacterial diseases, including cholera, that appear to be mediated via ADP-ribosylation.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Direct Link:
https://nih.technologypublisher.com/tech/Clones_Encoding_Mammalian_ADP-Ribosy larginine_Hydrolases
Category(s):
Licensing
Diagnostics
Infectious Disease
Therapeutics
Bookmark this page
Download as PDF
For Information, Contact:
Inteum Admin
NIH Technology Transfer
Inventors:
Joel Moss
Sally Stanley
Maria Nightingale
James Murtagh
Lucia Monaco
Tatsuyuki Takada
Keywords:
cholera
Cholera (Vibrio cholerae)
DA3XXX
DAXXXX
DB3XXX
DBXXXX
DXXXXX
Home
|
Search
|
RSS
|
Subscribe
© 2025. All Rights Reserved. Powered by
Inteum